首页|期刊导航|中华医学杂志（英文版）|Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience

Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience

Tian-Jiao Guo Xiao-Jun Huang Lei Wen Jin Lu

中华医学杂志（英文版）2017，Vol.130Issue(2)：239-241,3.

中华医学杂志（英文版）2017，Vol.130Issue(2)：239-241,3.DOI:10.4103/0366-6999.198017

Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience

Tian-Jiao Guo ¹Xiao-Jun Huang ²Lei Wen ¹Jin Lu¹

作者信息

1. Department of Hematology, Peking University People's Hospital and Peking University Institute of Hematology, Beijing 100044, China
2. Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing 100038, China
折叠

摘要

关键词

Bortezomib/Multiple Myeloma/Secondary Primary Malignancies

Key words

Bortezomib/Multiple Myeloma/Secondary Primary Malignancies

引用本文复制引用

Tian-Jiao Guo,Xiao-Jun Huang,Lei Wen,Jin Lu..Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience[J].中华医学杂志（英文版）,2017,130(2):239-241,3.

基金项目

This study partly supported by the National Natural Science Foundation of China (No.81670192). （No.81670192）

中华医学杂志（英文版）

OACSCDCSTPCD

ISSN：0366-6999

访问量0

下载量0

段落导航